Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

• Last SEC data release: 2026-04-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: A$3.94 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sanofi SNY	A$2.97 M	A$59.98 M	🇫🇷 France
Biogen BIIB	A$5.65 M	A$56.85 M	🇺🇸 USA
Bristol-Myers Squibb BMY	A$20.4 M	A$70.45 M	🇺🇸 USA
AstraZeneca AZN	A$45.08 M	A$0.17 B	🇬🇧 UK
GSK plc GSK	A$43.59 M	A$0.24 B	🇬🇧 UK
Sangamo Therapeutics SGMO	A$0.6 M	A$7.44 M	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	A$7.91 M	A$40.2 M	🇺🇸 USA